|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| New Pharmaceutical Chemistry | ||||||||||||||||
| March 04, 2002 | ||||||||||||||||
|
Wyndham Orlando, Orlando, FL April 4-5, 2002 SCHEDULED RIGHT BEFORE ACS NATIONAL MEETING! Organized Into Four Sections: - Lead Identification & Optimization - Structural Biology - Predictive Informatics & Computational Chemistry - High-Throughput Medicinal & Combinatorial Advances Featuring: The Promise of Genomics in the Future of Medicinal Chemistry - Structural GenomiX ChemoInformatics In the Era of Genomics: From Trial & Error to Prediction. - Aventis Pharmaceuticals Structure-Based Lead Identification & Optimization - Wyeth-Ayerst Research The Future of HTP Medicinal Chemistry - Hoffmann-La Roche |
||||||||||||||||
| Organized by: | Strategic Research Institute | |||||||||||||||
| Invited Speakers: | Keynote Speaker! Pharmaceutical Chemistry: When Will Wall Street Understand It's Value Stefan Loren, Ph.D. Managing Director Legg Mason Presentations By: Arqule Aventis Pharmaceuticals Berger Instruments Bristol-Myers Squibb Chiron Corporation Cytokinetics, Inc. Eli Lilly & Company Hoffmann-La Roche Legg Mason Millennium Pharmaceuticals Pfizer Global R&D Protein Pathways Simulation Plus, Inc. Structural BioInformatics Structural GenomiX Sunesis Pharmaceuticals Wyeth-Ayerst Research |
|||||||||||||||
| Deadline for Abstracts: | none | |||||||||||||||
| Registration: | www.srinstitute.com/cs186 (212) 967-0095 |
|||||||||||||||
| E-mail: | ckahan-radhuber@srinstitute.com | |||||||||||||||
| Posted by: | Cheryl Kahan-Radhuber | |||||||||||||||
| Host: | 12.3.58.15 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||